These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7035778)

  • 1. ELISA inhibition technique for the demonstration of sulphones in body fluids. The use of dried blood on filter paper to monitor leprosy patient compliance.
    Huikeshoven H; de Wit M; Soeters A; Landheer JE; Leiker DL; Niemer AQ; Warndorff T
    Lepr Rev; 1981 Sep; 52(3):221-8. PubMed ID: 7035778
    [No Abstract]   [Full Text] [Related]  

  • 2. ELISA inhibition technique for the demonstration of sulphones in body fluids. II. A new method to monitor leprosy patient compliance under field conditions.
    Huikeshoven H; de Wit M; Soeters A; Landheer J; Leiker DL
    Lepr Rev; 1981 Mar; 52(1):11-8. PubMed ID: 7017317
    [No Abstract]   [Full Text] [Related]  

  • 3. ELISA inhibition technique for the demonstration of sulphones in body fluids. I. Sulphones specific antibody-enzyme conjugate.
    Huikeshoven H; de Wit M; Soeters A; Eggelte TA; Landheer JE; Leiker DL
    Lepr Rev; 1979 Dec; 50(4):275-81. PubMed ID: 397386
    [No Abstract]   [Full Text] [Related]  

  • 4. ELISA inhibition technique for the demonstration of sulphones in body fluids. Comparison of two ELISA methods.
    de Wit M; Huikeshoven H; Soeters A; Eggelte TA; Landheer JE; Leiker DL
    Lepr Rev; 1981 Sep; 52(3):215-20. PubMed ID: 7035777
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemagglutination inhibition technique for the demonstration of sulphones in urine.
    Huikeshoven H; de Wit M; Eggelte TA; Landheer JE; Leiker DL
    Lepr Rev; 1981 Sep; 52(3):229-35. PubMed ID: 7329195
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of a dapsone compliance program in leprosy.
    Piscitelli SC; Danziger LH; Hill C; Slajchert AA; West DP; Fischer JH
    Int J Dermatol; 1993 Mar; 32(3):206-9. PubMed ID: 8444536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method for detecting sulfones in urine.
    Jaled MM; De Carli EI; Fariña MH; Gatti JC
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):560-1. PubMed ID: 3655470
    [No Abstract]   [Full Text] [Related]  

  • 9. Demonstration of dapsone in urine and serum by ELISA inhibition.
    Huikeshoven H; Landheer JE; van Denderen AC; Vlasman M; Leiker DL; Das PK; Goldring OL; Pondman KW
    Lancet; 1978 Feb; 1(8058):280-1. PubMed ID: 74707
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple urine spot test for monitoring dapsone self-administration in leprosy treatment.
    Huikeshoven H
    Bull World Health Organ; 1986; 64(2):279-81. PubMed ID: 3488843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do leprosy patients in Papua New Guinea take their dapsone?
    Ree GH; Taylor VE
    P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy.
    Balakrishnan S; Kumar A; Rao BR; Patro TP
    Indian J Lepr; 1986; 58(4):555-9. PubMed ID: 3572097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014
    [No Abstract]   [Full Text] [Related]  

  • 14. The drug treatment of leprosy.
    Browne SG
    Trans R Soc Trop Med Hyg; 1967; 61(2):265-71. PubMed ID: 6047760
    [No Abstract]   [Full Text] [Related]  

  • 15. CONCENTRATION OF D. D. SULPHIDE AND D. D. SULPHONE IN VARIOUS BODY FLUIDS: A COMPARATIVE STUDY.
    GHOSH S; KUNDU S; BOSE R
    Bull Calcutta Sch Trop Med; 1963 Apr; 11():52-3. PubMed ID: 14301721
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug compliance in the treatment of leprosy.
    Ellard GA
    Lepr Rev; 1981 Sep; 52(3):201-13. PubMed ID: 7035776
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of a urine spot test and blood tests as indicators of patient compliance.
    Yoder LJ; Guitrau M; Jacobson R
    Indian J Lepr; 1991; 63(2):195-202. PubMed ID: 1783788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administered drug compliance in Nepali leprosy patients.
    Roche PW; Failbus S; Britton W
    Trop Doct; 1989 Apr; 19(2):59-61. PubMed ID: 2734837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty years of leprosy control work--what next?
    Dharmendra
    Lepr India; 1980 Oct; 52(4):566-72. PubMed ID: 7464063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.